Publication | Closed Access
Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists
281
Citations
29
References
2004
Year
These data substantiate that drugs targeting macrophage LXR activity may offer therapeutic benefit in the treatment of atherosclerotic cardiovascular disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1